Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-12-04
1988-08-23
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514807, 530315, A61K 3734, C07K 716
Patent
active
047661089
ABSTRACT:
Vasopressin antagonists which have a dipeptide tail composed of a neutral and basic amino acid unit demonstrate potent V.sub.1 and V.sub.2 -antagonist activity. Two species of this invention, which are prepared by solid phase peptide synthesis, are [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylene propionic acid)-2-(O-ethyl)-D-tyrosine-4-valine-7-tyrosine-8-arginine-9-desglycine]- vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)-2-(O-ethyl)-D-tyrosine-4-valine-7-arginine-8-tyrosine-9-desglycine]- vasopressin.
REFERENCES:
patent: 4469679 (1984-09-01), Huffman et al.
patent: 4481193 (1984-11-01), Ali et al.
patent: 4481194 (1984-11-01), Ali et al.
Chem. Abstr. vol. 98 (1983) 126613.
Chem. Abstr. vol. 84 (1976) 54389.
Chem. Abstr. vol. 78 (1973) 157677.
Chem. Abstr. vol. 74 (1971) 9949.
Chem. Abstr. vol. 106 (1987) 27885.
Chem. Abstr. vol. 101 (1984) 17564.
Chem. Abstr. vol. 100 (1984) 115143.
Chem. Abstr. vol. 100 (1984) 51985.
M. Manning et al., Nature, 308, 652 (1984).
M. Manning et al., (9th American Peptide Symposium) pp. 599-602.
Lourie Alan D.
Phillips Delbert R.
Smith Kline Beckman Corporation
Suter Stuart R.
Williams Janice E.
LandOfFree
Tyr-Arg-vasopressin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tyr-Arg-vasopressin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyr-Arg-vasopressin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-835938